Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Miller

Showing results (171-180 of 290) with videos related to

Pageof 29
Sort By:
Research and Reports in Urology|March 3, 2021
Immunological Risk Factors in Paediatric Kidney TransplantationFrank Friedersdorff, Beatriz Banuelos-Marco, Marie-Therese Koch, et al.
The Journal of Urology|May 16, 2012
Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancerEvan Y Yu, Kurt Miller, Joel Nelson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 5, 2017
Immunohistochemical Validation of PSMA Expression Measured by <sup>68</sup>Ga-PSMA PET/CT in Primary Prostate CancerNadine Woythal, Ruza Arsenic, Carsten Kempkensteffen, et al.
World Journal of Urology|May 12, 2012
Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term resultsJonas Busch, Carsten Stephan, Annett Klutzny, et al.
BMC Urology|June 2, 2012
Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysisJonas Busch, Ahmed Magheli, Barbara Erber, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 24, 2007
Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcomeCarsten Kempkensteffen, Stefan Hinz, Frank Christoph, et al.
International Journal of Cancer|May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomyAnja Rabien, Florian R Fritzsche, Monika Jung, et al.
Journal of Hypertension|May 7, 2009
Transient receptor potential canonical type 3 channels and blood pressure in humansFlorian Thilo, Daniel Baumunk, Hans Krause, et al.
BMC Cancer|July 16, 2011
Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinomaJonas Busch, Christoph Seidel, Steffen Weikert, et al.
Urologia Internationalis|October 13, 2016
Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell CarcinomaBernhard Ralla, Ahmed Magheli, Ingmar Wolff, et al.
Pageof 29

Showing results (171-180 of 290) with videos related to

Sort By:
Pageof 29
Research and Reports in Urology|March 3, 2021
Immunological Risk Factors in Paediatric Kidney TransplantationFrank Friedersdorff, Beatriz Banuelos-Marco, Marie-Therese Koch, et al.
The Journal of Urology|May 16, 2012
Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancerEvan Y Yu, Kurt Miller, Joel Nelson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 5, 2017
Immunohistochemical Validation of PSMA Expression Measured by <sup>68</sup>Ga-PSMA PET/CT in Primary Prostate CancerNadine Woythal, Ruza Arsenic, Carsten Kempkensteffen, et al.
World Journal of Urology|May 12, 2012
Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term resultsJonas Busch, Carsten Stephan, Annett Klutzny, et al.
BMC Urology|June 2, 2012
Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysisJonas Busch, Ahmed Magheli, Barbara Erber, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 24, 2007
Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcomeCarsten Kempkensteffen, Stefan Hinz, Frank Christoph, et al.
International Journal of Cancer|May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomyAnja Rabien, Florian R Fritzsche, Monika Jung, et al.
Journal of Hypertension|May 7, 2009
Transient receptor potential canonical type 3 channels and blood pressure in humansFlorian Thilo, Daniel Baumunk, Hans Krause, et al.
BMC Cancer|July 16, 2011
Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinomaJonas Busch, Christoph Seidel, Steffen Weikert, et al.
Urologia Internationalis|October 13, 2016
Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell CarcinomaBernhard Ralla, Ahmed Magheli, Ingmar Wolff, et al.
Pageof 29